Registry for individuals with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The T1D Exchange Registry is an observational research initiative aimed at individuals with type 1 diabetes and their supporters. Participants voluntarily provide their data through annual surveys and have the option to engage in additional studies related to type 1 diabetes management. The study collects demographic and diabetes management information, which is updated annually, allowing for a comprehensive understanding of the condition over time. This registry serves as a valuable resource for future research and insights into type 1 diabetes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of type 1 diabetes.
* Individuals younger than 18 years of age must have parent/guardian consent.
* Must be able to read and understand English.
* Currently living in the United States

Exclusion criteria:

* Does not use insulin and has not had a pancreatic or islet cell transplant.
* Cannot fully read and understand English.
* Does not currently live in the United States.

Where it's running

• T1D Exchange
  Boston, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Kelsie LaFerrier
• Email: klaferriere@t1dexchange.org
• Phone: (617) 892-9941

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Omnipod 5 in France: one-year real-world follow-up (Optimal-B)

  This study will see if the Omnipod 5 automated insulin delivery system helps children and adults with type 1 diabetes in France improve glucose control, quality of life, and reduce acute diabetes complications over 12 months.

  Recruiting at 23 sites Insulet Corporation · Angers and 23 other locations · NCT07317102

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

• Optimizing diabetes foot care using eHealth tools

  This study is testing a new way to use digital tools to help people with diabetes take better care of their feet and prevent foot ulcers.

  Recruiting Sahlgrenska University Hospital · Gothenburg · NCT05692778

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• Genetic risk score and progression to insulin in type 1 diabetes

  This study tests whether a genetic risk score can predict which people with type 1 diabetes will need insulin progression over three years.

  Recruiting Second Xiangya Hospital of Central South University · Changsha, Hunan · NCT07621445

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.